Global‌ ‌focus‌ ‌event:‌ ‌
Institutionalizing‌ ‌evidence-informed‌ ‌
decision-making‌ ‌for‌ ‌effective‌ ‌health‌ ‌policy‌ ‌

Tuesday, 16 November 2021, 12:00-13:45 CET

Interpretation available: ARA, FRA, POR, RUS, SPA

> Session flyer

Evidence advisory bodies and governance mechanisms facilitating evidence-to-policy processes have received increasing recognition and support in recent years. Nonetheless, the COVID-19 pandemic in many countries revealed major gaps in sustainable, institutionalized knowledge translation capacities, and accelerated the creation and adaptation of a variety of evidence-to-policy translation tools and structures such as rapid evidence review and synthesis services. While some of these newly established support structures promise to have a positive, long-term impact for evidence-informed policy-making, much remains to be learned on how evidence-to-policy mechanisms are best created and sustained at country level.


Within WHO’s Evidence-informed Policy Network (EVIPNet), a globally leading initiative empowering countries to put actionable evidence in the hands of users, institutionalizing knowledge translation for more sustainable, resilient country capacities has been a strategic priority for over a decade. Incorporating lessons learned from before and during COVID-19, EVIPNet is currently developing a user-friendly tool to strengthen members’ efforts in institutionalizing evidence-informed policy-making. 


This focus event will bring together stakeholders such as policy-makers, researchers and civil society members to capitalize on key lessons in institutionalizing evidence-informed policy-making for more resilient health systems and offer first insights into the novel thematic EVIPNet-tool.

Key questions and session highlights 

During the first part of the session, speakers will reflect on the following key aspects:

  • What EIPM tools, mechanisms and governance structures countries developed or improved during the COVID-19 pandemic?

  • What were countries’ contributions to more resilient health systems?

  • To what extent have the successes and failures of evidence use during COVID-19 led to longer-term reflection, consideration and even more embedded or more routine use of evidence in policy-making?